Literature DB >> 2991442

Affinity-purified varicella-zoster virus glycoprotein gp1/gp3 stimulates the production of neutralizing antibody.

Z Wroblewska, D Gilden, M Green, M Devlin, A Vafai.   

Abstract

Varicella-zoster virus glycoprotein gp1/gp3 was purified by affinity chromatography using anti-gp1/gp3 monoclonal antibody 19.1 linked to CNBr-activated Sepharose CL-4B. Rabbits immunized with purified glycoprotein gp1/gp3 developed mono-specific neutralizing antibody.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2991442     DOI： 10.1099/0022-1317-66-8-1795

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  8 in total

1.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

2.  New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

Authors:  A J Davison; C M Edson; R W Ellis; B Forghani; D Gilden; C Grose; P M Keller; A Vafai; Z Wroblewska; K Yamanishi
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).

Authors:  P R Kinchington; P Ling; M Pensiero; B Moss; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.

Authors:  A Vafai; W N Yang
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus.

Authors:  J Davies; J A Hallworth; P McLeish; S Randall; B A Martin; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

6.  Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies.

Authors:  A Vafai; Z Wroblewska; R Mahalingam; G Cabirac; M Wellish; M Cisco; D Gilden
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.

Authors:  A Vafai; M Wellish; D H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 8.  Column liquid chromatography of integral membrane proteins.

Authors:  G W Welling; R van der Zee; S Welling-Wester
Journal:  J Chromatogr       Date:  1987-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.